SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000127
Filing Date
2023-06-27
Accepted
2023-06-27 07:54:43
Documents
16
Period of Report
2023-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20230623.htm   iXBRL 8-K 33516
2 EX-99.1 a062723-emergentannounce.htm EX-99.1 9924
6 a062723-emergentannounce001.jpg GRAPHIC 188509
7 a062723-emergentannounce002.jpg GRAPHIC 229567
8 a062723-emergentannounce003.jpg GRAPHIC 199811
  Complete submission text file 0001367644-23-000127.txt   1033622

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230623.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230623_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230623_pre.xml EX-101.PRE 13102
10 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230623_htm.xml XML 4436
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 231043994
SIC: 2834 Pharmaceutical Preparations